STAHL NEIL 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Aug 12, 2024
Insider Transaction Report
Form 4
STAHL NEIL
SVP Res and Dev Sciences
Transactions
- Sale
Common Stock
2024-08-08$1082.69/sh−200$216,538→ 55,896 total - Sale
Common Stock
2024-08-08$1083.76/sh−1,006$1,090,263→ 54,890 total - Sale
Common Stock
2024-08-08$1084.61/sh−1,883$2,042,321→ 53,007 total - Sale
Common Stock
2024-08-08$1085.01/sh−1,708$1,853,197→ 51,299 total - Sale
Common Stock
2024-08-08$1081.83/sh−100$108,183→ 56,096 total - Sale
Common Stock
2024-08-08$1086.15/sh−300$325,845→ 50,999 total - Gift
Common Stock
2024-08-12−900→ 50,099 total
Holdings
- 5,849(indirect: By 401(k))
Common Stock
- 4,605(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]Represents volume-weighted average price of sales of 100 shares of Company stock on August 8, 2024 at prices ranging from $1,081.75 to $1,081.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
- [F2]Represents volume-weighted average price of sales of 200 shares of Company stock on August 8, 2024 at prices ranging from $1,082.65 to $1,082.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
- [F3]Represents volume-weighted average price of sales of 1,006 shares of Company stock on August 8, 2024 at prices ranging from $1,083.27 to $1,083.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
- [F4]Represents volume-weighted average price of sales of 1,883 shares of Company stock on August 8, 2024 at prices ranging from $1,084.01 to $1,084.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
- [F5]Represents volume-weighted average price of sales of 1,708 shares of Company stock on August 8, 2024 at prices ranging from $1,085.00 to $1,085.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
- [F6]Represents volume-weighted average price of sales of 300 shares of Company stock on August 8, 2024 at prices ranging from $1,086.14 to $1,086.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.